y The company’s strategy is to improve its candidate surgical procedures in various ways, such as convert candidate open procedures to da Vinci Surgery; facilitate difficult MIS operations; and offer a less invasive single port surgical option. Distribution The company provides its products through a direct sales organization in the U.S.; majority of Western Europe excluding Spain, Portugal, Italy, and Greece; Japan; and Korea. In 2013, the company established a direct sales structure in the Czech Republic, Slovakia, and Hungary. In 2014, the company also established a direct sales structure in Japan. Research and Development The company invested $178.0 million of research and development expenses for the year ended December 31, 2014. It has alliances with various companies, including Erbe Elektromedizin GMBH; Johnson & Johnson; Olympus/Gyrus; Novadaq Technologies, Inc.; and Mimic Technologies, Inc. Intellectual Property As of December 31, 2014, the company held ownership or exclusive field-of-use licenses for approximately 1,700 U.S. and foreign patents, and approximately 1,500 U.S. and foreign patent applications. Intuitive, Intuitive Surgical, da Vinci, da Vinci S, da Vinci Si HD Surgical System, da Vinci S HD Surgical System, da Vinci Si, da Vinci Xi, da Vinci Si-e, da Vinci SP, EndoWrist, EndoWrist One, EndoWrist Stapler 45, Single-Site, Firefly, InSite, and da Vinci Connect are trademarks of the company. Competition The company faces competition from Ethicon Endo-Surgery, Inc. Government Regulation The company’s products and operations are subject to extensive and rigorous regulation by the FDA, the state of California and countries or regions in which the company markets its products. The FDA and the Federal Trade Commission also regulate the advertising claims of its products to ensure that the claims the company makes are consistent with its regulatory clearances. The company’s manufacturing processes are required to comply with the FDA’s Good Manufacturing Practice, requirements contained in its Quality System Regulation, and associated regulations and guidance. History Intuitive Surgical, Inc. was founded in 1995.
intuitive surgical inc (ISRG:NASDAQ GS)
1266 Kifer Road
Sunnyvale, CA 94086
|Cerner Corp||$59.61 USD||-1.20|
|CR Bard Inc||$187.01 USD||-3.38|
|Edwards Lifesciences Corp||$134.95 USD||-2.60|
|Endo International PLC||$72.67 USD||-1.79|
|Hologic Inc||$38.19 USD||-0.24|
|View Industry Companies|
Sponsored Financial Commentaries
To contact INTUITIVE SURGICAL INC, please visit www.intuitivesurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.